| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
New study highlights the value of a whole health approach managing chronic conditions and supporting members using GLP-1s
NEW YORK, Nov. 13, 2023 /PRNewswire/ -- DarioHealth Corp. (NASDAQ:DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced new research presented at the Diabetes Technology Society 2023 Meeting on November 7, 2023. The new research demonstrated the value of associating physical activity tracking alongside blood sugar tracking for people living with diabetes and pre-diabetes.
Dario's digital health solutions help drive healthier behaviors to improve the management of chronic conditions by combining a clinically intelligent platform with highly personalized digital and human coaching. Connected devices capture clinical and behavioral data into a single platform and billions of consumer insights can guide highly personalized journeys to measurably improve health outcomes. Dario's cardiometabolic solution integrates support for members managing diabetes, blood pressure and weight, with a special program for those taking a GLP-1, or anti-obesity medication, collecting clinical measurements along with activity, diet and medication information to support a whole health approach.
The new study examined the blood glucose and walking data of 989 Dario users to understand the impact of integrating clinical and behavioral data in a single digital app-based experience. The results demonstrated significantly reduced blood glucose levels in the first four months of using Dario and increased step levels in the same timeframe maintained for 12 months. In addition, the results demonstrated clinically significant reductions in blood glucose levels in users who tracked at least 400 steps per day.
"I believe this new research shows the potential for an integrated digital solution to help people manage their overall health. We are excited to share this new data as another example of how our highly personalized approach to improving behaviors can help people take control of their overall health and realize better results," said Yifat Hershcovitz, Ph.D., Vice President of Clinical and Scientific Affairs at Dario.
"Improving health behaviors is the key to improving outcomes, and Dario is intensely focused on the intersection of those behaviors with clinical intelligence gained from more than a decade of consumer engagement. We are excited to see this new study shed light on the impact a singular focus on whole health can have for our members and our partners," said Omar Manejwala, M.D., Chief Medical Officer of Dario.
The research was conducted in partnership with the Integrative Pain Laboratory, School of Public Health at the University of Haifa.
Posted In: DRIO
